Wei H - Search Results

1

Engineered Exosomes as Theranostic Platforms for Cancer Treatment.

Yang X, Xie X, Liu S, Ma W, Zheng Z, Wei H, Yu CY. Yang X, et al. Among authors: wei h. ACS Biomater Sci Eng. 2023 Oct 9;9(10):5479-5503. doi: 10.1021/acsbiomaterials.3c00745. Epub 2023 Sep 11. ACS Biomater Sci Eng. 2023. PMID: 37695590 Review.

2

Direct observation of time and temperature dependent transition from spherical micelles to vesicles.

Wei H, Yu CY, Chang C, Quan CY, Mo SB, Cheng SX, Zhang XZ, Zhuo RX. Wei H, et al. Chem Commun (Camb). 2008 Oct 14;(38):4598-600. doi: 10.1039/b811553b. Epub 2008 Aug 1. Chem Commun (Camb). 2008. PMID: 18815696

3

In vitro and in vivo evaluation of pectin-based nanoparticles for hepatocellular carcinoma drug chemotherapy.

Yu CY, Wang YM, Li NM, Liu GS, Yang S, Tang GT, He DX, Tan XW, Wei H. Yu CY, et al. Among authors: wei h. Mol Pharm. 2014 Feb 3;11(2):638-44. doi: 10.1021/mp400412c. Epub 2014 Jan 9. Mol Pharm. 2014. PMID: 24383625

4

Cyclodextrin-functionalized polymers as drug carriers for cancer therapy.

Wei H, Yu CY. Wei H, et al. Biomater Sci. 2015 Jul;3(7):1050-60. doi: 10.1039/c4bm00417e. Epub 2015 Feb 23. Biomater Sci. 2015. PMID: 26221939

5

Delivery of Liver-Specific miRNA-122 Using a Targeted Macromolecular Prodrug toward Synergistic Therapy for Hepatocellular Carcinoma.

Ning Q, Liu YF, Ye PJ, Gao P, Li ZP, Tang SY, He DX, Tang SS, Wei H, Yu CY. Ning Q, et al. Among authors: wei h. ACS Appl Mater Interfaces. 2019 Mar 20;11(11):10578-10588. doi: 10.1021/acsami.9b00634. Epub 2019 Mar 8. ACS Appl Mater Interfaces. 2019. PMID: 30802029

6

Micelles with Cyclic Poly(ε-caprolactone) Moieties: Greater Stability, Larger Drug Loading Capacity, and Slower Degradation Property for Controlled Drug Release.

Kang G, Sun L, Liu Y, Meng C, Ma W, Wang B, Ma L, Yu C, Wei H. Kang G, et al. Among authors: wei h. Langmuir. 2019 Sep 24;35(38):12509-12517. doi: 10.1021/acs.langmuir.9b02346. Epub 2019 Sep 11. Langmuir. 2019. PMID: 31487459

7

Cell membrane-camouflaged nanoparticles as drug carriers for cancer therapy.

Xu CH, Ye PJ, Zhou YC, He DX, Wei H, Yu CY. Xu CH, et al. Among authors: wei h. Acta Biomater. 2020 Mar 15;105:1-14. doi: 10.1016/j.actbio.2020.01.036. Epub 2020 Jan 28. Acta Biomater. 2020. PMID: 32001369 Review.

8

Modulation of cyclic topology toward enhanced drug delivery, from linear and tadpole-like to dumbbell-shaped copolymers.

Kang G, Liu Y, Li L, Sun L, Ma W, Meng C, Ma L, Zheng G, Chang C, Wei H. Kang G, et al. Among authors: wei h. Chem Commun (Camb). 2020 Mar 10;56(20):3003-3006. doi: 10.1039/c9cc09878j. Chem Commun (Camb). 2020. PMID: 32044897

9

Synthesis of cyclic graft polymeric prodrugs with heterogeneous grafts of hydrophilic OEG and reducibly conjugated CPT for controlled release.

Meng C, Cao Y, Sun L, Liu Y, Kang G, Ma W, Peng J, Deng K, Ma L, Wei H. Meng C, et al. Among authors: wei h. Biomater Sci. 2020 Jul 28;8(15):4206-4215. doi: 10.1039/d0bm00656d. Biomater Sci. 2020. PMID: 32555884

10

Facile Fabrication of Nanoparticles with Dual-Targeting Ligands for Precise Hepatocellular Carcinoma Therapy In Vitro and In Vivo.

Xiang Y, Huang W, Huang C, Long J, Zhou Y, Liu Y, Tang S, He DX, Tan XW, Wei H, Yu CY. Xiang Y, et al. Among authors: wei h. Mol Pharm. 2020 Sep 8;17(9):3223-3235. doi: 10.1021/acs.molpharmaceut.0c00327. Epub 2020 Jul 27. Mol Pharm. 2020. PMID: 32658485

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,516 results

Search Page

Filters